Pursuant to the Announcement of NMPA on Issues Pertaining to Implementing the Provisions for Drug Registration and the deployment of NMPA, to promote the drafting and formulation of related supporting normative documents and technical guidelines, the Center for Drug Evaluation organized the revision of the Administrative Measures for Communication of Drug R&D and Technical Review, which has, as per the requirements of the Notice of the NMPA Comprehensive Department on Issuing the Release Procedures for Pharmaceutical Technical Guidelines, been released with NMPA's examination and approval for implementation as from December 10, 2020.